Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trigeminal Nerve Diseases | 2 | 2011 | 2 | 0.700 |
Why?
|
| Positron-Emission Tomography | 7 | 2014 | 259 | 0.530 |
Why?
|
| Tomography, Emission-Computed | 11 | 2003 | 58 | 0.430 |
Why?
|
| Brain | 11 | 2008 | 2371 | 0.400 |
Why?
|
| Bipolar Disorder | 8 | 2014 | 205 | 0.390 |
Why?
|
| Skin Ulcer | 1 | 2011 | 13 | 0.370 |
Why?
|
| Hypesthesia | 1 | 2011 | 16 | 0.370 |
Why?
|
| Trigeminal Nerve | 1 | 2011 | 28 | 0.370 |
Why?
|
| Nose Diseases | 1 | 2011 | 11 | 0.370 |
Why?
|
| Nose | 1 | 2011 | 55 | 0.360 |
Why?
|
| Laryngoscopy | 1 | 2011 | 91 | 0.340 |
Why?
|
| Bronchoscopy | 1 | 2011 | 245 | 0.320 |
Why?
|
| Depressive Disorder, Major | 5 | 2014 | 301 | 0.260 |
Why?
|
| Nerve Net | 1 | 2008 | 226 | 0.260 |
Why?
|
| Prefrontal Cortex | 8 | 2014 | 262 | 0.240 |
Why?
|
| Depressive Disorder | 5 | 2008 | 332 | 0.220 |
Why?
|
| Brain Mapping | 7 | 2008 | 524 | 0.220 |
Why?
|
| Health Status | 1 | 2008 | 722 | 0.220 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 50 | 0.200 |
Why?
|
| Cerebrovascular Circulation | 8 | 2008 | 221 | 0.190 |
Why?
|
| Transcranial Magnetic Stimulation | 4 | 2003 | 44 | 0.180 |
Why?
|
| Blood Glucose | 2 | 2002 | 1828 | 0.130 |
Why?
|
| Glucose | 4 | 2008 | 897 | 0.120 |
Why?
|
| Amygdala | 2 | 2014 | 170 | 0.120 |
Why?
|
| Cerebral Cortex | 3 | 2005 | 380 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 2 | 2008 | 56 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 8 | 2014 | 113 | 0.120 |
Why?
|
| Hearing | 1 | 2014 | 134 | 0.100 |
Why?
|
| Aging | 1 | 2002 | 1618 | 0.100 |
Why?
|
| Male | 22 | 2014 | 55667 | 0.100 |
Why?
|
| Middle Aged | 14 | 2014 | 26740 | 0.090 |
Why?
|
| Laryngomalacia | 1 | 2011 | 5 | 0.090 |
Why?
|
| Cyclohexanols | 2 | 2005 | 9 | 0.090 |
Why?
|
| Pharyngeal Diseases | 1 | 2011 | 12 | 0.090 |
Why?
|
| Trigeminal Neuralgia | 1 | 2011 | 10 | 0.090 |
Why?
|
| Utah | 1 | 2011 | 59 | 0.090 |
Why?
|
| Bupropion | 2 | 2005 | 39 | 0.090 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 38 | 0.090 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2005 | 38 | 0.090 |
Why?
|
| Rhinoplasty | 1 | 2011 | 23 | 0.090 |
Why?
|
| Papillomaviridae | 1 | 2011 | 101 | 0.090 |
Why?
|
| Adult | 20 | 2014 | 30561 | 0.090 |
Why?
|
| Brain Chemistry | 2 | 2001 | 115 | 0.090 |
Why?
|
| Hippocampus | 1 | 2014 | 694 | 0.080 |
Why?
|
| Surgical Flaps | 1 | 2011 | 121 | 0.080 |
Why?
|
| Reoperation | 1 | 2011 | 514 | 0.080 |
Why?
|
| Female | 21 | 2014 | 59571 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2011 | 234 | 0.080 |
Why?
|
| Humans | 24 | 2014 | 114709 | 0.070 |
Why?
|
| Cell Count | 1 | 2008 | 303 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 261 | 0.070 |
Why?
|
| Accidents, Traffic | 1 | 2008 | 170 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2002 | 731 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2009 | 444 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2008 | 759 | 0.070 |
Why?
|
| Electromagnetic Phenomena | 2 | 2008 | 22 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 577 | 0.060 |
Why?
|
| Affect | 2 | 2014 | 246 | 0.060 |
Why?
|
| Temporal Lobe | 3 | 2005 | 79 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2011 | 9089 | 0.060 |
Why?
|
| Anxiety | 2 | 2000 | 840 | 0.060 |
Why?
|
| Periodicity | 1 | 2003 | 55 | 0.060 |
Why?
|
| Motor Cortex | 1 | 2003 | 47 | 0.050 |
Why?
|
| Pain | 1 | 2009 | 705 | 0.050 |
Why?
|
| Reference Values | 2 | 2002 | 743 | 0.050 |
Why?
|
| Emotions | 3 | 2014 | 472 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 4411 | 0.050 |
Why?
|
| Cross-Over Studies | 4 | 2008 | 440 | 0.050 |
Why?
|
| Mood Disorders | 2 | 2000 | 112 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2008 | 482 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2002 | 131 | 0.050 |
Why?
|
| Radiopharmaceuticals | 4 | 2005 | 157 | 0.050 |
Why?
|
| Depression | 1 | 2008 | 1135 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2011 | 2128 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2011 | 5048 | 0.040 |
Why?
|
| Gyrus Cinguli | 2 | 2014 | 70 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2008 | 685 | 0.040 |
Why?
|
| Nimodipine | 1 | 1999 | 7 | 0.040 |
Why?
|
| Antimanic Agents | 1 | 1999 | 14 | 0.040 |
Why?
|
| Carbamazepine | 1 | 1999 | 18 | 0.040 |
Why?
|
| Anger | 1 | 1999 | 55 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 114 | 0.040 |
Why?
|
| Infant | 1 | 2011 | 7968 | 0.040 |
Why?
|
| Functional Laterality | 3 | 2005 | 198 | 0.040 |
Why?
|
| Acoustic Stimulation | 2 | 2014 | 314 | 0.040 |
Why?
|
| Procaine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Sensation | 1 | 1996 | 44 | 0.030 |
Why?
|
| Limbic System | 1 | 1996 | 43 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2008 | 127 | 0.030 |
Why?
|
| Magnetoencephalography | 2 | 2008 | 104 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2011 | 12557 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2008 | 1660 | 0.030 |
Why?
|
| Rest | 1 | 2014 | 103 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2014 | 159 | 0.030 |
Why?
|
| Skull | 2 | 2003 | 119 | 0.030 |
Why?
|
| Venlafaxine Hydrochloride | 2 | 2005 | 11 | 0.020 |
Why?
|
| Aged | 4 | 2002 | 19075 | 0.020 |
Why?
|
| Mouth | 1 | 2011 | 70 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 292 | 0.020 |
Why?
|
| Oxygen Radioisotopes | 1 | 2008 | 3 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 1036 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1695 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 424 | 0.020 |
Why?
|
| Psychometrics | 1 | 2008 | 608 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2008 | 476 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 927 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2005 | 258 | 0.010 |
Why?
|
| Demography | 1 | 2005 | 260 | 0.010 |
Why?
|
| Differential Threshold | 1 | 2003 | 5 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 928 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 2540 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2001 | 158 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1999 | 77 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 3004 | 0.010 |
Why?
|
| Comorbidity | 1 | 2000 | 1448 | 0.010 |
Why?
|
| Hallucinations | 1 | 1996 | 30 | 0.010 |
Why?
|
| Auditory Perception | 1 | 1996 | 102 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1999 | 641 | 0.010 |
Why?
|
| Visual Perception | 1 | 1996 | 139 | 0.010 |
Why?
|
| Animals | 1 | 1999 | 31710 | 0.000 |
Why?
|
| Adolescent | 1 | 1996 | 17854 | 0.000 |
Why?
|